Plasma beta-glucuronidase activity: A novel tool to distinguish type 1 from type 2 amiodarone-induced thyrotoxicosis?
European Thyroid Journal Jul 18, 2019
Markantes GK, et al. - Since amiodarone-induced thyrotoxicosis (AIT) is a common and deleterious side effect of amiodarone use and it is often very difficult to discriminate between Type 1 (AIT1) and Type 2 (AIT2) AIT, researchers sought to explore whether determining the plasma activity of β-G would be helpful in separating AIT1 from AIT2. Participants in the study were 67 subjects: 9 with AIT1, 9 with AIT2, 14 with hyperthyroidism due to Grave’s disease or toxic multinodular goiter, 14 with subacute thyroiditis, and 21 euthyroid controls. In distinguishing AIT1 from AIT2, plasma β-G activity (expressed as mean ± SD in nmol 4-methylumbelliferone [4-MU]/mL plasma/h) was performed well. Between AIT1 and controls, β-G activity did not differ significantly.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries